Back to search
PE - Pulmonary Embolism
Clinical trial pipeline · Data from ClinicalTrials.gov
See which PE - Pulmonary Embolism trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which PE - Pulmonary Embolism trials you may qualify forRandomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care
Pulmonary embolism (PE) is a serious and potentially life-threatening condition caused by blood clots in the lungs. A particular type, subsegmental pulmonary em…
Venous thromboembolism (VTE) and atherosclerotic cardiovascular disease share common risk factors and frequently coexist in the same patients. Their management…
This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alone for inter…
This study is researching an experimental drug called REGN7508 versus Acetylsalicylic Acid (ASA) (each called "study drug"). The study is focused on adults unde…
This registry is a global prospective, non-randomized, multicenter, observational, active post-market data collection of Inari Medical devices and products.
Acute pulmonary embolism (PE) in critically ill patients is common and often life threatening. The diagnosis of acute PE is often entertained in intensive care…
This study aims to compare clinical scoring systems, laboratory biomarkers, and computed tomography (CT) findings in patients diagnosed with acute pulmonary emb…